Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Piclamilast

Copy Product Info
😃Good
Catalog No. T23154Cas No. 144035-83-6
Alias RPR 73401, RP 73401

Piclamilast (RP 73401) is a PDE4 inhibitor.

Piclamilast

Piclamilast

Copy Product Info
😃Good
Purity: 99.57%
Catalog No. T23154Alias RPR 73401, RP 73401Cas No. 144035-83-6
Piclamilast (RP 73401) is a PDE4 inhibitor.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$44In StockIn Stock
5 mg$98In StockIn Stock
10 mg$163In StockIn Stock
25 mg$328In StockIn Stock
50 mg$529In StockIn Stock
100 mg$753-In Stock
1 mL x 10 mM (in DMSO)$113In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.57%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Piclamilast (RP 73401) is a PDE4 inhibitor.
Targets&IC50
PDE2:40 μM, PDE3:>100 μM, PDE1:>100 μM, PDE5:14 μM, PDE4:16 nM (pig aorta), PDE4:2 nM (eosinophil soluble)
In vitro
Piclamilast pre-treatment significantly inhibited the changes in 23 genes via mechanisms involving AP-1 activation and c-Jun phosphorylation at Ser63[1]. The IC50s for Piclamilast was 16 nM and 2 nM in pig aorta and eosinophil soluble, respectively. Piclamilast exhibited IC50 values >100 μM, 40 μM, >100 μM, 14 μM for PDE1, PDE2, PDE3 and PDE5. Respectively[4].
In vivo
Initial in vivo studies conducted in severe combined immunodeficiency mice transplanted with NB4 leukemia cells indicate that the enhancing effect of piclamilast on ATRA-induced myeloid maturation translates into a therapeutic benefit[2].
SynonymsRPR 73401, RP 73401
Chemical Properties
Molecular Weight381.25
FormulaC18H18Cl2N2O3
Cas No.144035-83-6
SmilesCOc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl
Relative Density.1.37g/cm3
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 30 mg/mL (78.69 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
In Vivo Formulation
10% DMSO+90% Corn Oil: 2 mg/mL (5.25 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6230 mL13.1148 mL26.2295 mL131.1475 mL
5 mM0.5246 mL2.6230 mL5.2459 mL26.2295 mL
10 mM0.2623 mL1.3115 mL2.6230 mL13.1148 mL
20 mM0.1311 mL0.6557 mL1.3115 mL6.5574 mL
50 mM0.0525 mL0.2623 mL0.5246 mL2.6230 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Piclamilast | purchase Piclamilast | Piclamilast cost | order Piclamilast | Piclamilast chemical structure | Piclamilast in vivo | Piclamilast in vitro | Piclamilast formula | Piclamilast molecular weight